Trial intelligence / Profile preview

Primary Prevention with Pravastatin in Hypercholesterolemia - Japan Study

jRCT1080220524

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of pravastatin in hypercholesterolemia and atherosclerotic disease, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occlusive atherosclerotic complications.

02

Drugs

pravastatin
03

Conditions

hypercholesterolemiaatherosclerotic disease

Beyond the preview

Go deeper on jRCT1080220524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call